China In-Situ Hybridization Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • In Situ Hybridization (ISH)

    In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section. The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China In-Situ Hybridization market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China In-Situ Hybridization market. Detailed analysis of key players, along with key growth strategies adopted by In-Situ Hybridization industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Abbott Laboratories

    • Bio SB

    • Merck

    • Leica Biosystems Nussloch

    • Thermo Fisher Scientific

    • BioGenex Laboratories

    • Advanced Cell Diagnostics

    • F Hoffmann-La Roche

    • PerkinElmer

    • Agilent Technologies

    • Exiqon A/S

    By Type:

    • Radioactive isotopes

    • Non-radioactive labels

    By End-User:

    • Cancer Diagnosis

    • Immunology

    • Neuroscience

    • Cytology

    • Infectious Diseases

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of In-Situ Hybridization Market

    • 1.3 Market Segment by Type

    • 1.3.1 China In-Situ Hybridization Market Size and Growth Rate of Radioactive isotopes from 2016 to 2027

    • 1.3.2 China In-Situ Hybridization Market Size and Growth Rate of Non-radioactive labels from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China In-Situ Hybridization Market Size and Growth Rate of Cancer Diagnosis from 2016 to 2027

    • 1.4.2 China In-Situ Hybridization Market Size and Growth Rate of Immunology from 2016 to 2027

    • 1.4.3 China In-Situ Hybridization Market Size and Growth Rate of Neuroscience from 2016 to 2027

    • 1.4.4 China In-Situ Hybridization Market Size and Growth Rate of Cytology from 2016 to 2027

    • 1.4.5 China In-Situ Hybridization Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of In-Situ Hybridization Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of In-Situ Hybridization by Major Types

    • 3.4.1 Market Size and Growth Rate of Radioactive isotopes

    • 3.4.2 Market Size and Growth Rate of Non-radioactive labels

    4 Segmentation of In-Situ Hybridization Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of In-Situ Hybridization by Major End-Users

    • 4.4.1 Market Size and Growth Rate of In-Situ Hybridization in Cancer Diagnosis

    • 4.4.2 Market Size and Growth Rate of In-Situ Hybridization in Immunology

    • 4.4.3 Market Size and Growth Rate of In-Situ Hybridization in Neuroscience

    • 4.4.4 Market Size and Growth Rate of In-Situ Hybridization in Cytology

    • 4.4.5 Market Size and Growth Rate of In-Situ Hybridization in Infectious Diseases

    5 Market Analysis by Regions

    • 5.1 China In-Situ Hybridization Production Analysis by Regions

    • 5.2 China In-Situ Hybridization Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China In-Situ Hybridization Landscape Analysis

    • 6.1 North China In-Situ Hybridization Landscape Analysis by Major Types

    • 6.2 North China In-Situ Hybridization Landscape Analysis by Major End-Users

    7 Central China In-Situ Hybridization Landscape Analysis

    • 7.1 Central China In-Situ Hybridization Landscape Analysis by Major Types

    • 7.2 Central China In-Situ Hybridization Landscape Analysis by Major End-Users

    8 South China In-Situ Hybridization Landscape Analysis

    • 8.1 South China In-Situ Hybridization Landscape Analysis by Major Types

    • 8.2 South China In-Situ Hybridization Landscape Analysis by Major End-Users

    9 East China In-Situ Hybridization Landscape Analysis

    • 9.1 East China In-Situ Hybridization Landscape Analysis by Major Types

    • 9.2 East China In-Situ Hybridization Landscape Analysis by Major End-Users

    10 Northeast China In-Situ Hybridization Landscape Analysis

    • 10.1 Northeast China In-Situ Hybridization Landscape Analysis by Major Types

    • 10.2 Northeast China In-Situ Hybridization Landscape Analysis by Major End-Users

    11 Southwest China In-Situ Hybridization Landscape Analysis

    • 11.1 Southwest China In-Situ Hybridization Landscape Analysis by Major Types

    • 11.2 Southwest China In-Situ Hybridization Landscape Analysis by Major End-Users

    12 Northwest China In-Situ Hybridization Landscape Analysis

    • 12.1 Northwest China In-Situ Hybridization Landscape Analysis by Major Types

    • 12.2 Northwest China In-Situ Hybridization Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Abbott Laboratories

      • 13.1.1 Abbott Laboratories Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bio SB

      • 13.2.1 Bio SB Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Merck

      • 13.3.1 Merck Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Leica Biosystems Nussloch

      • 13.4.1 Leica Biosystems Nussloch Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Thermo Fisher Scientific

      • 13.5.1 Thermo Fisher Scientific Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 BioGenex Laboratories

      • 13.6.1 BioGenex Laboratories Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Advanced Cell Diagnostics

      • 13.7.1 Advanced Cell Diagnostics Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 F Hoffmann-La Roche

      • 13.8.1 F Hoffmann-La Roche Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 PerkinElmer

      • 13.9.1 PerkinElmer Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Agilent Technologies

      • 13.10.1 Agilent Technologies Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Exiqon A/S

      • 13.11.1 Exiqon A/S Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Radioactive isotopes from 2016 to 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Non-radioactive labels from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Cancer Diagnosis from 2016 to 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Immunology from 2016 to 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Neuroscience from 2016 to 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Cytology from 2016 to 2027

    • Figure China In-Situ Hybridization Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China In-Situ Hybridization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of In-Situ Hybridization Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of In-Situ Hybridization

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of In-Situ Hybridization by Different Types from 2016 to 2027

    • Table Consumption Share of In-Situ Hybridization by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Radioactive isotopes

    • Figure Market Size and Growth Rate of Non-radioactive labels

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of In-Situ Hybridization by Different End-Users from 2016 to 2027

    • Table Consumption Share of In-Situ Hybridization by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cancer Diagnosis

    • Figure Market Size and Growth Rate of Immunology

    • Figure Market Size and Growth Rate of Neuroscience

    • Figure Market Size and Growth Rate of Cytology

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Table China In-Situ Hybridization Production by Regions

    • Table China In-Situ Hybridization Production Share by Regions

    • Figure China In-Situ Hybridization Production Share by Regions in 2016

    • Figure China In-Situ Hybridization Production Share by Regions in 2021

    • Figure China In-Situ Hybridization Production Share by Regions in 2027

    • Table China In-Situ Hybridization Consumption by Regions

    • Table China In-Situ Hybridization Consumption Share by Regions

    • Figure China In-Situ Hybridization Consumption Share by Regions in 2016

    • Figure China In-Situ Hybridization Consumption Share by Regions in 2021

    • Figure China In-Situ Hybridization Consumption Share by Regions in 2027

    • Table North China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table North China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure North China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure North China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure North China In-Situ Hybridization Consumption Share by Types in 2027

    • Table North China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table North China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure North China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure North China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure North China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table Central China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table Central China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure Central China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure Central China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure Central China In-Situ Hybridization Consumption Share by Types in 2027

    • Table Central China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table Central China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure Central China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure Central China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure Central China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table South China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table South China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure South China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure South China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure South China In-Situ Hybridization Consumption Share by Types in 2027

    • Table South China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table South China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure South China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure South China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure South China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table East China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table East China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure East China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure East China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure East China In-Situ Hybridization Consumption Share by Types in 2027

    • Table East China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table East China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure East China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure East China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure East China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table Northeast China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table Northeast China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure Northeast China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure Northeast China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure Northeast China In-Situ Hybridization Consumption Share by Types in 2027

    • Table Northeast China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table Northeast China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure Northeast China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure Northeast China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table Southwest China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table Southwest China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure Southwest China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure Southwest China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure Southwest China In-Situ Hybridization Consumption Share by Types in 2027

    • Table Southwest China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table Southwest China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure Southwest China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure Southwest China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table Northwest China In-Situ Hybridization Consumption by Types from 2016 to 2027

    • Table Northwest China In-Situ Hybridization Consumption Share by Types from 2016 to 2027

    • Figure Northwest China In-Situ Hybridization Consumption Share by Types in 2016

    • Figure Northwest China In-Situ Hybridization Consumption Share by Types in 2021

    • Figure Northwest China In-Situ Hybridization Consumption Share by Types in 2027

    • Table Northwest China In-Situ Hybridization Consumption by End-Users from 2016 to 2027

    • Table Northwest China In-Situ Hybridization Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China In-Situ Hybridization Consumption Share by End-Users in 2016

    • Figure Northwest China In-Situ Hybridization Consumption Share by End-Users in 2021

    • Figure Northwest China In-Situ Hybridization Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Bio SB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio SB

    • Figure Sales and Growth Rate Analysis of Bio SB

    • Figure Revenue and Market Share Analysis of Bio SB

    • Table Product and Service Introduction of Bio SB

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Leica Biosystems Nussloch

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Leica Biosystems Nussloch

    • Figure Sales and Growth Rate Analysis of Leica Biosystems Nussloch

    • Figure Revenue and Market Share Analysis of Leica Biosystems Nussloch

    • Table Product and Service Introduction of Leica Biosystems Nussloch

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of BioGenex Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioGenex Laboratories

    • Figure Sales and Growth Rate Analysis of BioGenex Laboratories

    • Figure Revenue and Market Share Analysis of BioGenex Laboratories

    • Table Product and Service Introduction of BioGenex Laboratories

    • Table Company Profile and Development Status of Advanced Cell Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Cell Diagnostics

    • Figure Sales and Growth Rate Analysis of Advanced Cell Diagnostics

    • Figure Revenue and Market Share Analysis of Advanced Cell Diagnostics

    • Table Product and Service Introduction of Advanced Cell Diagnostics

    • Table Company Profile and Development Status of F Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Product and Service Introduction of F Hoffmann-La Roche

    • Table Company Profile and Development Status of PerkinElmer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer

    • Figure Sales and Growth Rate Analysis of PerkinElmer

    • Figure Revenue and Market Share Analysis of PerkinElmer

    • Table Product and Service Introduction of PerkinElmer

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies

    • Table Company Profile and Development Status of Exiqon A/S

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exiqon A/S

    • Figure Sales and Growth Rate Analysis of Exiqon A/S

    • Figure Revenue and Market Share Analysis of Exiqon A/S

    • Table Product and Service Introduction of Exiqon A/S


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.